Articles
Vol. 35 No. 5 (2013)
https://doi.org/10.4081/pmc.2013.31

Epoprostenol for very low birth weight (VLBW) infants: a novel dilution protocol

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 17 November 2014
Accepted: 17 November 2014
Published: 31 October 2013
1319
Views
1247
Downloads
Epoprostenol, very low birth weight infants, infants

Authors

S. Rugolotto
simone.rugolotto@ospedaleuniverona.it
Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
R. Beghini
Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
I. Cogo
Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
G. Sidoti
Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
E.M. Padovani
Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
A. Pietrobelli
Department of Pediatrics, Section of Newborn Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
Epoprostenol has been the first effective treatment for severe pulmonary arterial hypertension. Epoprostenol is provided in vials for adult therapy. To our knowledge there are no reports on specific dilution protocols for epoprostenol in VLBW infants, when very small infusion rates are required. We describe the dilution protocol we applied to a preterm infant who was born at 30 weeks of gestational age with a weight of 1.000 g. Our dilution protocol keeps the recommended dilution ratios, and the required solution pH, for very small dosages of epoprostenol, using the same diluent vial. Our method allows a correct and safe administration of epoprostenol in VLBW infants.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite



Epoprostenol for very low birth weight (VLBW) infants: a novel dilution protocol. (2013). La Pediatria Medica E Chirurgica, 35(5). https://doi.org/10.4081/pmc.2013.31